Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharmacogenomics. 2012 Apr;13(5):529-31. doi: 10.2217/pgs.12.8.

Company profile: Sequenom, Inc.

Author information

1
Sequenom, Inc., 3595 John Hopkins Ct, San Diego, CA 92121, USA. ccantor@sequenom.com

Abstract

There is broad acceptance in both the research and clinical communities that the age of personalized medicine is rapidly approaching. Numerous examples of biomarkers (and tests based on those biomarkers) have been shown to be relevant to clinically important phenotypes. Sequenom, Inc. is at the forefront of this molecular medicine revolution. The company provides genetic analysis instrumentation and reagents to the clinical and research communities. These products are being used for clinical validation of relevant biomarkers as well as for development of diagnostic tests based on those biomarkers.

PMID:
22462745
DOI:
10.2217/pgs.12.8
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center